Non-Alcoholic Fatty Liver Disease (NAFLD) and Bariatric/Metabolic Surgery as Its Treatment Option: A Review
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Non-Alcoholic Fatty Liver Disease (NAFLD) and Bariatric/Metabolic Surgery as Its Treatment Option: A Review
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 10, Issue 24, Pages 5721
Publisher
MDPI AG
Online
2021-12-08
DOI
10.3390/jcm10245721
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bariatric Surgery and Cardiovascular Outcomes in Patients With Obesity and Cardiovascular Disease:
- (2021) Aristithes G. Doumouras et al. CIRCULATION
- Gastric Bypass Compared with Sleeve Gastrectomy for Nonalcoholic Fatty Liver Disease: a Systematic Review and Meta-analysis
- (2021) Miller Barreto de Brito e Silva et al. OBESITY SURGERY
- Pioglitazone even at low dosage improves NAFLD in type 2 diabetes: clinical and pathophysiological insights from a subgroup of the TOSCA.IT randomised trial
- (2021) Giuseppe Della Pepa et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Effects of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Non-Alcoholic Fatty Liver Disease: A 12-Month Follow-Up Study with Paired Liver Biopsies
- (2021) Julie Steen Pedersen et al. Journal of Clinical Medicine
- Reduction of Major Adverse Cardiovascular Events (MACE) after Bariatric Surgery in Patients with Obesity and Cardiovascular Diseases: A Systematic Review and Meta-Analysis
- (2021) Andryanto Sutanto et al. Nutrients
- Selonsertib for Patients with Bridging Fibrosis or Compensated Cirrhosis Due to NASH: Results from Randomized Ph III STELLAR Trials
- (2020) Stephen A. Harrison et al. JOURNAL OF HEPATOLOGY
- Bariatric Surgery in Obesity: Effects on Gut Microbiota and Micronutrient Status
- (2020) Daniela Ciobârcă et al. Nutrients
- Effect of Weight Loss Medications on Hepatic Steatosis and Steatohepatitis: A Systematic Review
- (2020) Chelsea S. Pan et al. Frontiers in Endocrinology
- Effect of weight loss induced by laparoscopic sleeve gastrectomy on liver histology and serum adipokine levels
- (2020) Ahmed Abdallah Salman et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
- (2020) Judith Aron-Wisnewsky et al. Nature Reviews Gastroenterology & Hepatology
- The Prevalence of NAFLD and Fibrosis in Bariatric Surgery Patients and the Reliability of Noninvasive Diagnostic Methods
- (2020) Maurizio Soresi et al. Biomed Research International
- Liraglutide Attenuates Non-Alcoholic Fatty Liver Disease in Mice by Regulating the Local Renin-Angiotensin System
- (2020) Mengying Yang et al. Frontiers in Pharmacology
- Evaluation of NAFLD and fibrosis in obese patients – a comparison of histological and clinical scoring systems
- (2020) Sophia Marie-Therese Schmitz et al. BMC GASTROENTEROLOGY
- PNPLA3 and nonalcoholic fatty liver disease: towards personalized medicine for fatty liver
- (2020) Liyun Yuan et al. Hepatobiliary Surgery and Nutrition
- Baseline Presence of NAFLD Predicts Weight Loss after Gastric Bypass Surgery for Morbid Obesity
- (2020) Karl Peter Rheinwalt et al. Journal of Clinical Medicine
- Metabolomic Profiles Predict Diabetes Remission after Bariatric Surgery
- (2020) Jane Ha et al. Journal of Clinical Medicine
- Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH
- (2020) Rohit Loomba et al. HEPATOLOGY
- Dietary and Pharmacological Treatment of Nonalcoholic Fatty Liver Disease
- (2019) Anna Jeznach-Steinhagen et al. Medicina-Lithuania
- Impact of sleeve gastrectomy and Roux-en-Y gastric bypass on biopsy-proven non-alcoholic fatty liver disease
- (2019) Deepa V. Cherla et al. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
- Metformin attenuates the onset of non-alcoholic fatty liver disease and affects intestinal microbiota and barrier in small intestine
- (2019) Annette Brandt et al. Scientific Reports
- Systematic review and meta-analysis of Roux-en-Y gastric bypass against laparoscopic sleeve gastrectomy for amelioration of NAFLD using four criteria
- (2019) Dustin Baldwin et al. Surgery for Obesity and Related Diseases
- Farnesoid X nuclear receptor agonists for the treatment of nonalcoholic steatohepatitis
- (2019) Vasiliki Venetsanaki et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Nonalcoholic Steatohepatitis After Liver Transplantation
- (2019) Thomas G. Cotter et al. LIVER TRANSPLANTATION
- Laparoscopic sleeve gastrectomy reverses non-alcoholic fatty liver disease modulating oxidative stress and inflammation
- (2019) Noemí Cabré et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Liraglutide Improves Non-Alcoholic Fatty Liver Disease In Diabetic Mice By Modulating Inflammatory Signaling Pathways
- (2019) Ying Luo et al. Drug Design Development and Therapy
- Response to Pioglitazone in Patients With Nonalcoholic Steatohepatitis With vs Without Type 2 Diabetes
- (2018) Fernando Bril et al. Clinical Gastroenterology and Hepatology
- Simtuzumab Is Ineffective for Patients with Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis
- (2018) Stephen A. Harrison et al. GASTROENTEROLOGY
- Laparoscopic Sleeve Gastrectomy Improves Nonalcoholic Fatty Liver Disease–Related Liver Damage in Adolescents by Reshaping Cellular Interactions and Hepatic Adipocytokine Production
- (2018) Valerio Nobili et al. JOURNAL OF PEDIATRICS
- Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD)
- (2018) Pegah Golabi et al. MEDICINE
- 2018 annual report of the European Liver Transplant Registry (ELTR) - 50-year evolution of liver transplantation
- (2018) René Adam et al. TRANSPLANT INTERNATIONAL
- Complete Resolution of Nonalcoholic Fatty Liver Disease After Bariatric Surgery: A Systematic Review and Meta-Analysis
- (2018) Yung Lee et al. Clinical Gastroenterology and Hepatology
- The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial
- (2017) Rohit Loomba et al. HEPATOLOGY
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
- (2017) Chris Estes et al. HEPATOLOGY
- How bariatric surgery affects liver volume and fat density in NAFLD patients
- (2017) Ran B. Luo et al. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
- Magnetic resonance imaging and transient elastography in the management of Nonalcoholic Fatty Liver Disease (NAFLD)
- (2017) Ma Ai Thanda Han et al. Expert Review of Clinical Pharmacology
- Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus
- (2016) Kenneth Cusi et al. ANNALS OF INTERNAL MEDICINE
- Loss of Junctional Adhesion Molecule A Promotes Severe Steatohepatitis in Mice on a Diet High in Saturated Fat, Fructose, and Cholesterol
- (2016) Khalidur Rahman et al. GASTROENTEROLOGY
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- The Natural Course of Non-Alcoholic Fatty Liver Disease
- (2016) Luis Calzadilla Bertot et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- Lipotoxic lethal and sublethal stress signaling in hepatocytes: relevance to NASH pathogenesis
- (2016) Petra Hirsova et al. JOURNAL OF LIPID RESEARCH
- The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
- (2016) Elena Buzzetti et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The role of the gut microbiota in NAFLD
- (2016) Christopher Leung et al. Nature Reviews Gastroenterology & Hepatology
- Comparative efficacy of anti-diabetic agents on nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized and non-randomized studies
- (2015) Wenjuan Tang et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- G01 : Liraglutide is effective in the histological clearance of non-alcoholic steatohepatitis in a multicentre, doubleblinded, randomised, placebo-controlled phase II trial
- (2015) M.J. Armstrong et al. JOURNAL OF HEPATOLOGY
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease
- (2014) Julia Kozlitina et al. NATURE GENETICS
- Effect of Roux-en-y Gastric Bypass on Nonalcoholic Fatty Liver Disease Evaluated Through NAFLD Fibrosis Score: a Prospective Study
- (2014) Everton Cazzo et al. OBESITY SURGERY
- Weight Loss in Nonalcoholic Fatty Liver Disease Patients in an Ambulatory Care Setting Is Largely Unsuccessful but Correlates with Frequency of Clinic Visits
- (2014) Anwar Dudekula et al. PLoS One
- Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease
- (2014) Nancy Khov WORLD JOURNAL OF GASTROENTEROLOGY
- Mechanisms of changes in glucose metabolism and bodyweight after bariatric surgery
- (2014) Sten Madsbad et al. Lancet Diabetes & Endocrinology
- Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: Current and Potential Future Treatments
- (2014) Akira Sasaki et al. Frontiers in Endocrinology
- Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
- (2013) Sunder Mudaliar et al. GASTROENTEROLOGY
- Increased De Novo Lipogenesis Is a Distinct Characteristic of Individuals With Nonalcoholic Fatty Liver Disease
- (2013) Jennifer E. Lambert et al. GASTROENTEROLOGY
- Characteristics and diagnosis of NAFLD/NASH
- (2013) Etsuko Hashimoto et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- The burden of liver disease in Europe: A review of available epidemiological data
- (2013) Martin Blachier et al. JOURNAL OF HEPATOLOGY
- The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease
- (2013) Halina Cichoż-Lach et al. MEDICAL SCIENCE MONITOR
- Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
- (2013) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- Long-Term Effect of Bariatric Surgery on Liver Enzymes in the Swedish Obese Subjects (SOS) Study
- (2013) Maria Antonella Burza et al. PLoS One
- Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD
- (2012) Z. Permutt et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering property
- (2012) Hideyuki Hyogo et al. DIGESTIVE AND LIVER DISEASE
- The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
- (2012) Naga Chalasani et al. HEPATOLOGY
- Lipid Targets During Statin Treatment in Dyslipidemic Patients Affected by Nonalcoholic Fatty Liver Disease
- (2011) Lorenzo Maroni et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008
- (2011) Zobair M. Younossi et al. Clinical Gastroenterology and Hepatology
- Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy
- (2011) Scott B. Reeder et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Association Between Composition of the Human Gastrointestinal Microbiome and Development of Fatty Liver With Choline Deficiency
- (2010) Melanie D. Spencer et al. GASTROENTEROLOGY
- Generalizability of the Nonalcoholic Steatohepatitis Clinical Research Network Histologic Scoring System for Nonalcoholic Fatty Liver Disease
- (2010) Ravi Juluri et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Histopathology of nonalcoholic fatty liver disease
- (2010) Elizabeth M Brunt WORLD JOURNAL OF GASTROENTEROLOGY
- Prospective Study of the Long-Term Effects of Bariatric Surgery on Liver Injury in Patients Without Advanced Disease
- (2009) Philippe Mathurin et al. GASTROENTEROLOGY
- The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver
- (2009) Nicola L. Beer et al. HUMAN MOLECULAR GENETICS
- Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis
- (2008) R. LOOMBA et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Effect of Bariatric Surgery on Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
- (2008) Rajasekhara R. Mummadi et al. Clinical Gastroenterology and Hepatology
- Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial
- (2008) Vlad Ratziu et al. GASTROENTEROLOGY
- Liver cirrhosis
- (2008) Detlef Schuppan et al. LANCET
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
- (2008) Stefano Romeo et al. NATURE GENETICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started